Cepheid, a global leader in molecular diagnostics and part of the Danaher group, has announced the appointment of Ashish Gupta as General Manager for India and South Asia.
In this strategic role, Ashish will lead the company’s operations and growth across the region, driving efforts to expand access to fast, accurate, and accessible molecular diagnostic solutions. Cepheid’s mission to improve patient outcomes through timely and reliable testing aligns closely with Ashish’s deep commitment to healthcare advancement.
“I’m honored to join Cepheid at such a pivotal time,” said Ashish Gupta. “Together with our teams and partners, I look forward to helping transform healthcare across India and South Asia by ensuring innovative diagnostic technologies reach those who need them most.”
With extensive experience in healthcare leadership and business transformation, Ashish will spearhead initiatives to strengthen regional partnerships, enhance healthcare infrastructure, and support public health priorities.
His appointment underscores Cepheid’s continued commitment to innovation and impact in emerging markets.